Speaker illustration

Doctor Maarten Vanhaverbeke

AZ Delta, Roeselare (Belgium)

Member of:

European Society of Cardiology

Dr. Vanhaverbeke graduated as cardiologist at the University Hospitals Leuven, Belgium in 2019. He obtained his PhD in ischemic heart disease and finished an additional 2-year training in interventional cardiology. He also completed a one-year training in percutaneous structural interventions at Rigshospitalet, Copenhagen, Denmark, covering valve interventions such as TAVI and other structural interventions including LAA occlusion. He has specific interest in ischemic heart disease, percutaneous coronary intervention, intracoronary imaging and percutaneous structural heart interventions. His research topics include inflammation and precision medicine in acute coronary syndrome and clinical research in structural heart interventions. He was active in the EU-CardioRNA COST Action CA17129 and former treasurer of the Young Cardiologists' Club, a working group of the Belgian Society of Cardiology. He is a full-time interventional cardiologist in AZ Delta, Roeselare, Belgium.

Unbiased gene expression signature in acute coronary syndromes identifies mediators of inflammasome signaling correlating with infarct size

Event: ESC Congress 2016

Topic: Infarction acute phase STEMI

Session: Blood markers in acute coronary syndrome


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb